Spectral CT Clinical Trial Protocol

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-04

Study Completion Date

2023-02-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to evaluate the expected effectiveness, ease of operation, stability, and safety of Spectral CT

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CT 5400 RT System Application Clinical Study

NCT06595888

Computed Tomography Workflow Assessment

COMPLETED NA

Clinical Study of CT 5400 RT for Precise Image Validation

NCT06589934

Precise Image (AI Reconstruction Feature of CT 5400 RT System)

COMPLETED NA

Comparison of Spectral Photon Counting CT (SPCCT) With Dual Energy CT (DECT) and Magnetic Resonance Imaging (MRI) for Plaque and Lumen Carotid Arteries Evaluation

NCT04466787

Supra-Aortic Stenosis

COMPLETED NA

Incisive CT Clinica Trial Protocol

NCT05020262

CT Images

UNKNOWN

Algorithms to Diagnose Pulmonary Arterial Hypertension

NCT05417373

Pulmonary Arterial Hypertension

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Under the premise of protecting subjects and ensuring the scientific nature of this study, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal conditions by collecting clinical cases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CT Scanning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group, all volunteer will be scanned.

All participation accept Spectral CT scanning; No group;

Group Type EXPERIMENTAL

Spectral CT

Intervention Type DEVICE

Using Spectral CT to scan Breast

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spectral CT

Using Spectral CT to scan Breast

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recruit volunteers (ages 18 to 75);
* Negative pregnancy tests in women of childbearing age;
* Participants who agree to participate in this clinical trial and sign the informed consent;
* Enhanced scans require laboratory tests to confirm normal renal function.

Exclusion Criteria

* Persons who do not have full capacity for civil conduct;
* Lactating women;
* People who are not suitable for enhanced scanning with iodine contrast agent;
* Patients whom the investigator considers inappropriate to participate in this clinical trial.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes